• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

血液系统恶性肿瘤侵袭性真菌病的风险分类与预防建议：证据与专家意见的批判性综述（TEO-4）

Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).

作者信息

Boğa Can, Bolaman Zahit, Çağırgan Seçkin, Karadoğan İhsan, Özcan Mehmet Ali, Özkalemkaş Fahir, Saba Rabin, Sönmez Mehmet, Şenol Esin, Akan Hamdi, Akova Murat

机构信息

Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey Phone: +90 532 424 26 40 E-mail:

出版信息

Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277.

DOI:10.4274/tjh.2014.0277
PMID:26316478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4451478/
Abstract

This is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.

摘要

这是土耳其的意见领袖撰写的关于侵袭性真菌感染系列文章中的最后一篇。这些文章的目的是根据该领域现有的最佳证据，指导临床医生管理血液系统恶性肿瘤和干细胞移植中的侵袭性真菌疾病。之前的文章总结了侵袭性真菌疾病的诊断和治疗，本文旨在解释风险分类并指导侵袭性真菌疾病的抗真菌预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/4451478/110f7a304308/TJH-32-100-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/4451478/110f7a304308/TJH-32-100-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/4451478/110f7a304308/TJH-32-100-g6.jpg

相似文献

1
Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).血液系统恶性肿瘤侵袭性真菌病的风险分类与预防建议：证据与专家意见的批判性综述（TEO-4）
Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277.
2
A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction.一项准实验研究，分析便携式高效微粒吸收过滤器在预防血液学患者在建筑施工期间感染方面的有效性。
Turk J Haematol. 2016 Mar 5;33(1):41-7. doi: 10.4274/tjh.2014.0010. Epub 2014 May 21.
3
Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.血液系统恶性肿瘤患者发热性中性粒细胞减少症中的继发感染：不止是又一次发热性中性粒细胞减少发作。
Turk J Haematol. 2015 Sep;32(3):243-50. doi: 10.4274/tjh.2013.0422.
4
Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.血液学和干细胞移植受者侵袭性真菌病的危险因素及预防：一个不断发展的领域。
Expert Rev Anti Infect Ther. 2016 Dec;14(12):1165-1177. doi: 10.1080/14787210.2016.1245613. Epub 2016 Oct 22.
5
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.血液病成人意大利研究组、骨髓移植意大利研究组、意大利儿科血液学和肿瘤学会、欧洲癌症研究与治疗组织侵袭性真菌感染合作组和恶性血液病真菌感染监测研究组关于血液恶性肿瘤和造血干细胞移植受者中性粒细胞减少患者抗真菌策略的血液学共识协议。
Hematol Oncol. 2013 Sep;31(3):117-26. doi: 10.1002/hon.2031. Epub 2012 Oct 5.
6
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.血液恶性肿瘤的真菌初级预防：随机对照试验的网络荟萃分析。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00355-18. Print 2018 Aug.
7
[Invasive fungal infection management in patients with hematological malignancies].[血液系统恶性肿瘤患者侵袭性真菌感染的管理]
Rinsho Ketsueki. 2022;63(9):1270-1278. doi: 10.11406/rinketsu.63.1270.
8
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).癌症患者侵袭性真菌感染的治疗——德国血液与肿瘤学会感染病工作组（AGIHO）2019 年修订建议。
Mycoses. 2020 Jul;63(7):653-682. doi: 10.1111/myc.13082. Epub 2020 May 12.
9
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study.免疫功能低下的发热性中性粒细胞减少症患者中假定非致病性真菌介导的真菌血症患病率：一项前瞻性队列研究
J Hematol Oncol. 2024 Aug 7;17(1):63. doi: 10.1186/s13045-024-01583-0.
10
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.使用甲硝唑、环丙沙星和氟康唑或环丙沙星与氟康唑进行肠道去污的异基因骨髓移植后的真菌定植和侵袭性真菌感染。
Bone Marrow Transplant. 2000 Nov;26(9):993-7. doi: 10.1038/sj.bmt.1702655.

引用本文的文献

1
Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye.土耳其血液系统恶性肿瘤高危患者的抗真菌预防：实践与指南的比较
Turk J Med Sci. 2024 Nov 29;55(1):52-64. doi: 10.55730/1300-0144.5942. eCollection 2025.
2
Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China.氟康唑在预防异基因干细胞移植后早期侵袭性真菌病方面与其他抗霉菌药物效果相当：中国血液系统疾病抗真菌治疗评估
Transl Cancer Res. 2020 Nov;9(11):6900-6911. doi: 10.21037/tcr-19-2887.
3

本文引用的文献

1
Immune correlates of protection in human invasive aspergillosis.人类侵袭性曲霉菌病的免疫保护相关性。
Clin Infect Dis. 2014 Aug 15;59(4):569-77. doi: 10.1093/cid/ciu337. Epub 2014 May 6.
2
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO).异基因造血干细胞移植中侵袭性真菌病的一级预防：意大利骨髓移植协作组（GITMO）共识流程的修订建议
Biol Blood Marrow Transplant. 2014 Aug;20(8):1080-8. doi: 10.1016/j.bbmt.2014.02.018. Epub 2014 Feb 26.
3
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.
Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.
从土耳其爱琴海地区分离的耶氏肺孢子菌菌株中缺乏二氢蝶酸合酶基因突变。
Parasitol Res. 2018 Oct;117(10):3103-3108. doi: 10.1007/s00436-018-6004-6. Epub 2018 Jul 19.
造血干细胞移植后遗传性纤溶酶原激活物抑制因子-3 缺乏与曲霉菌病
N Engl J Med. 2014 Jan 30;370(5):421-32. doi: 10.1056/NEJMoa1211161.
4
Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.造血干细胞移植后系统性抗真菌预防：荟萃分析。
Clin Ther. 2014 Feb 1;36(2):292-306.e1. doi: 10.1016/j.clinthera.2013.11.010. Epub 2014 Jan 17.
5
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.预测急性髓细胞白血病或高级别骨髓增生异常综合征强化诱导化疗期间的不良事件。
Am J Hematol. 2014 Apr;89(4):423-8. doi: 10.1002/ajh.23661. Epub 2014 Feb 24.
6
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.抗真菌药物的治疗药物监测（TDM）：英国医学真菌学会指南
J Antimicrob Chemother. 2014 May;69(5):1162-76. doi: 10.1093/jac/dkt508. Epub 2013 Dec 29.
7
The role of primary antifungal prophylaxis in patients with haematological malignancies.原发性抗真菌预防在血液恶性肿瘤患者中的作用。
Clin Microbiol Infect. 2014 Jun;20 Suppl 6:19-26. doi: 10.1111/1469-0691.12464. Epub 2014 Feb 3.
8
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.2013 年 IDSA 免疫功能低下宿主疫苗接种临床实践指南。
Clin Infect Dis. 2014 Feb;58(3):e44-100. doi: 10.1093/cid/cit684. Epub 2013 Dec 4.
9
Influenza vaccines in immunosuppressed adults with cancer.癌症免疫抑制成人的流感疫苗
Cochrane Database Syst Rev. 2013 Oct 29;2013(10):CD008983. doi: 10.1002/14651858.CD008983.pub2.
10
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.预防血液系统恶性肿瘤患者和造血干细胞移植受者的侵袭性真菌病：实际问题。
J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii5-16. doi: 10.1093/jac/dkt389.